The efficacy of sildenafil in different etiologies of erectile dysfunction

International Urology and Nephrology

Volumn 32, Issue 3, 2001, Pages 403-407

  Murat Basar M ^a   Tekdogan U Y ^b   Yilmaz, E ^a   Basar H ^a   Atan, A ^b   Batislam, E ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Erectile dysfunction; Oral medication; Sildenafil

Indexed keywords

SILDENAFIL;

ADULT; ARTERY DISEASE; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULAR DISEASE; VEIN OCCLUSION;

ADULT; AGED; HUMANS; IMPOTENCE; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PENIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; REGIONAL BLOOD FLOW; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 0034851222     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017554300171     Document Type: Article

References (40)

1. Impotence and its medical and psychological correlates: Results of the Massechussets male aging study
2. The epidemiology of erectile dysfunction
3. Psychological issues in diagnosis and treatment of erectile disorders
4. Long-term results of penile prosthetic implants
5. Penile revascularization
6. Treatment of erectile dysfunction with external vacuum devices
7. Intracavernous injection therapy for male erectile dysfunction
8. Intracavernosal self-injection therapy in men with erectile dysfunction and attrition in 119 patients
9. 1 SERA gel for the treatment of erectile dysfunction
10. Hemodynamic effects of transurethral alprostadil measured by color duplex ultrasonography in men with erectile dysfunction
11. Trazodone, A double blind trial for treatment of erectile dysfunction
12. A nitric oxide-like factor mediates nonadrenergic noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle
13. Nitric oxide: A physiologic mediator of penile erection
14. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve anatomy in the rat
15. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction
16. Oral and topical treatment of erectile dysfunction
17. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction
18. Oral trazodone as empirical therapy for erectile dysfunction a retrospective study
19. Oral androgens in the treatment of hypogonadal men
20. Effect of large doses of nitric oxide precursor L-arginine on erectile failure
21. Oral sildenafil (Viagra) in the treatment of erectile dysfunction: Assessment of erections hard enough for sexual intercourse
22. Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction
23. Indications and early results of sildenafil (Viagra) in erectile dysfunction
24. Efficacy of sildenafil (Viagra) is not affected by etiology of erectile dysfunction
25. Sildenafil (Viagra) efficacy in the treatment of erectile dysfunction in patients with common concomitant conditations
26. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment
27. A 36-week, open label, non-comparative study to assess the long-term safety of sildenafil (Viagra) in patients with erectile dysfunction
28. Sildenafil, a novel effective oral therapy for male erectile dysfunction
29. Medical treatment of erectile dysfunction
30. Hemodynamic effects of sildenafil in men with severe coronary artery disease
31. Sildenafil: A review of its use in erectile dysfunction
32. Triggering of cardiac events: Findings from a case-crossover analysis
33. Use of sildenafil (Viagra) in patients with cardiovascular disease
34. Sildenafil and nonnitrate antihypertansive medications
35. Cardiovascular effects of sildenafil citrate and recommendations for its use
36. Sildenafil: A new oral therapy for erectile dysfunction
37. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: A double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group
38. Sildenafil (Viagra) in the treatment of erectile dysfunction: Analysis of two flexible dose-escalation studies
39. Sildenafil (Viagra): Analysis of preferred dose in a European, 6-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction
40. Sildenafil (Viagra) overall safety profile in 18 double-blind, placebo-controlled, clinical trials of erectile dysfunction